BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28548040)

  • 1. PAQR3 Inhibits the Proliferation and Tumorigenesis in Esophageal Cancer Cells.
    Zhou F; Wang S; Wang J
    Oncol Res; 2017 May; 25(5):663-671. PubMed ID: 28548040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAQR3 overexpression suppresses the aggressive phenotype of esophageal squamous cell carcinoma cells via inhibition of ERK signaling.
    Bai G; Chu J; Eli M; Bao Y; Wen H
    Biomed Pharmacother; 2017 Oct; 94():813-819. PubMed ID: 28802234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAQR3 inhibits the proliferation, migration and invasion in human glioma cells.
    Tang SL; Gao YL; Hu WZ
    Biomed Pharmacother; 2017 Aug; 92():24-32. PubMed ID: 28528182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAQR3 plays a suppressive role in laryngeal squamous cell carcinoma.
    Wu Q; Zhuang K; Li H
    Tumour Biol; 2016 Jan; 37(1):561-5. PubMed ID: 26232324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumor suppressor role of PAQR3 in osteosarcoma.
    Ma Z; Wang Y; Piao T; Li Z; Zhang H; Liu Z; Liu J
    Tumour Biol; 2015 May; 36(5):3319-24. PubMed ID: 25510670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of PAQR3 suppresses extracellular matrix accumulation in high glucose-stimulated human glomerular mesangial cells via PI3K/AKT signaling pathway.
    Li H; Wang Y; Chen B; Shi J
    Eur J Pharmacol; 2018 Aug; 832():50-55. PubMed ID: 29787774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of PAQR3 as a new candidate tumor suppressor in hepatocellular carcinoma.
    Wu HG; Zhang WJ; Ding Q; Peng G; Zou ZW; Liu T; Cao RB; Fei SJ; Li PC; Yang KY; Hu JL; Dai XF; Wu G; Li PD
    Oncol Rep; 2014 Dec; 32(6):2687-95. PubMed ID: 25310770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAQR3 expression is downregulated in human breast cancers and correlated with HER2 expression.
    Li Z; Ling ZQ; Guo W; Lu XX; Pan Y; Wang Z; Chen Y
    Oncotarget; 2015 May; 6(14):12357-68. PubMed ID: 25900239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DDB2 is involved in ubiquitination and degradation of PAQR3 and regulates tumorigenesis of gastric cancer cells.
    Qiao S; Guo W; Liao L; Wang L; Wang Z; Zhang R; Xu D; Zhang Y; Pan Y; Wang Z; Chen Y
    Biochem J; 2015 Aug; 469(3):469-80. PubMed ID: 26205499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of miR-15b-5p promotes gastric cancer metastasis by regulating PAQR3.
    Zhao C; Li Y; Chen G; Wang F; Shen Z; Zhou R
    Oncol Rep; 2017 Jul; 38(1):352-358. PubMed ID: 28560431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting p21-activated kinase 1 inhibits growth and metastasis via Raf1/MEK1/ERK signaling in esophageal squamous cell carcinoma cells.
    Chen L; Bi S; Hou J; Zhao Z; Wang C; Xie S
    Cell Commun Signal; 2019 Apr; 17(1):31. PubMed ID: 30971268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-137 upregulation increases bladder cancer cell proliferation and invasion by targeting PAQR3.
    Xiu Y; Liu Z; Xia S; Jin C; Yin H; Zhao W; Wu Q
    PLoS One; 2014; 9(10):e109734. PubMed ID: 25330156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of G3BP1 suppresses proliferation, migration, and invasion of esophageal cancer cells via Wnt/β-catenin and PI3K/AKT signaling pathways.
    Zhang LN; Zhao L; Yan XL; Huang YH
    J Cell Physiol; 2019 Nov; 234(11):20469-20484. PubMed ID: 30989663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAQR3 plays a suppressive role in the tumorigenesis of colorectal cancers.
    Wang X; Li X; Fan F; Jiao S; Wang L; Zhu L; Pan Y; Wu G; Ling ZQ; Fang J; Chen Y
    Carcinogenesis; 2012 Nov; 33(11):2228-35. PubMed ID: 22828136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAQR3 protects against oxygen-glucose deprivation/reperfusion-induced injury through the ERK signaling pathway in N2A cells.
    Peng W; Mo X; Li L; Lu T; Hu Z
    J Mol Histol; 2020 Jun; 51(3):307-315. PubMed ID: 32448978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway.
    Zhu L; Zhang X; Fu X; Li Z; Sun Z; Wu J; Wang X; Wang F; Li X; Niu S; Ding M; Yang Z; Yang W; Yin M; Zhang L; Zhang M
    J Transl Med; 2018 Jan; 16(1):7. PubMed ID: 29343267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAQR3 inhibits proliferation via suppressing PI3K/AKT signaling pathway in non-small cell lung cancer.
    Li X; Li M; Chen D; Shi G; Zhao H
    Arch Med Sci; 2018 Oct; 14(6):1289-1297. PubMed ID: 30393483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of PAQR3 gene promoter hypermethylation in breast cancer and prognosis.
    Chen J; Wang F; Xu J; He Z; Lu Y; Wang Z
    Oncol Rep; 2016 Sep; 36(3):1612-8. PubMed ID: 27461225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-574-3p inhibits proliferation and invasion in esophageal cancer by targeting FAM3C and MAPK1.
    Jin LL; Zhang SJ; Lu GX; Lv F; Shang R; Yang J
    Kaohsiung J Med Sci; 2020 May; 36(5):318-327. PubMed ID: 31880039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ras-related tumorigenesis is suppressed by BNIP3-mediated autophagy through inhibition of cell proliferation.
    Wu SY; Lan SH; Cheng DE; Chen WK; Shen CH; Lee YR; Zuchini R; Liu HS
    Neoplasia; 2011 Dec; 13(12):1171-82. PubMed ID: 22241963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.